MEDS — Income Statement (Laba Rugi)
Laporan Keuangan Ringkasan laba rugi, neraca, dan arus kas — MEDS PT Hetzer Medical Indonesia Tbk
| Dalam Jutaan IDR | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|
| Total Pendapatan | 4,767 | 6,629 | 4,951 | 3,152 | 1,814 | 6,391 | 6,760 | 5,441 |
| Total Beban Pokok Penjualan | (3,064) | (6,029) | (4,412) | (2,829) | (1,584) | (5,540) | (3,256) | (2,621) |
| Laba Kotor | 1,704 | 600 | 539 | 323 | 229 | 851 | 3,505 | 2,820 |
| Total Beban Usaha | (2,055) | (8,871) | (6,032) | (4,047) | (1,924) | (9,524) | (8,506) | (6,058) |
| Laba Usaha | (351) | (8,270) | (5,492) | (3,723) | (1,695) | (8,674) | (5,002) | (3,238) |
| Penghasilan/Beban Lain-Lain | 676 | (297) | (229) | (147) | (89) | 400 | (515) | (463) |
| Laba Sebelum Pajak | 325 | (8,568) | (5,721) | (3,870) | (1,783) | (8,274) | (5,517) | (3,701) |
| Beban Pajak Penghasilan | - | 222 | - | - | - | (260) | 3 | 3 |
| Laba Bersih Dari Operasi Yang Dilanjutkan | 325 | (8,346) | (5,721) | (3,870) | (1,783) | (8,534) | (5,513) | (3,697) |
| Hak Minoritas | - | - | - | - | - | - | - | - |
| Penyesuaian Proforma | - | - | - | - | - | - | - | - |
| Laba Bersih Tahun Berjalan | 325 | (8,346) | (5,721) | (3,870) | (1,783) | (8,534) | (5,513) | (3,697) |
| Pendapatan Komprehensif Lain | - | 27 | - | - | - | (5) | (17) | (17) |
| Jumlah Laba Komprehensif | 325 | (8,319) | (5,721) | (3,870) | (1,783) | (8,539) | (5,531) | (3,715) |
| Laba Bersih Yang Dapat Diatribusikan | 325 | (8,346) | (5,721) | (3,870) | (1,783) | (8,534) | (5,513) | (3,697) |
| Laba Komprehensif Yang Dapat Diatribusikan | 325 | (8,319) | (5,721) | (3,870) | (1,783) | (8,539) | (5,531) | (3,715) |
Key Ratios — MEDS
| Rasio | Q1 2026 ×4 | Q4 2025 | Q3 2025 ×1⅓ | Q2 2025 ×2 | Q1 2025 ×4 | Q4 2024 | Q3 2024 ×1⅓ | Q2 2024 ×2 |
|---|---|---|---|---|---|---|---|---|
| Profitabilitas | ||||||||
| Gross Margin (%) | 35.74% | 9.06% | 10.89% | 10.26% | 12.65% | 13.31% | 51.84% | 51.83% |
| Operating Margin (%) | 7.37% | 124.76% | 110.93% | 118.10% | 93.42% | 135.72% | 73.99% | 59.52% |
| Net Margin (%) | 6.81% | 125.90% | 115.55% | 122.75% | 98.31% | 133.52% | 81.55% | 67.96% |
| ROE (%) | 2.67% | 17.28% | 14.99% | 14.67% | 13.01% | 15.07% | 12.33% | 12.04% |
| ROA (%) | 2.04% | 13.51% | 12.18% | 12.12% | 11.04% | 13.07% | 10.82% | 10.47% |
| Per Lembar Saham | ||||||||
| EPS (Rp) | 0,83 | 5,34 | 4,88 | 4,95 | 4,56 | 5,46 | 4,70 | 4,73 |
| BVPS (Rp) | 31,12 | 30,91 | 32,57 | 33,76 | 35,09 | 36,23 | 38,16 | 39,32 |
| Valuasi | ||||||||
| PER (x) | 91.57x | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PBV (x) | 2.44x | 2.46x | 2.33x | 2.25x | 2.17x | 2.10x | 1.99x | 1.93x |
| Struktur Modal | ||||||||
| DER (x) | 0.31x | 0.28x | 0.23x | 0.21x | 0.18x | 0.15x | 0.14x | 0.15x |